Eskulap Chomasp. j.

Dispensing chemist in specialised stores

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2001-10-31
Registered address
Wilczyńskiego 1, 08-300 Sokołów Podlaski, Poland
Electronic delivery address
AE:PL-52467-40653-WVSTD-21

Financials

Filing timeliness

Financial statements were filed on time, on average 94 days early.

  • 202531/03/2026
  • 202431/03/2025
  • 202329/03/2024
  • 202229/03/2023
  • 202123/06/2022
  • 202022/06/2021
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2025.

Results vs industry

Revenue
This companyUSD 541.71kMedianUSD 1.92mAverageUSD 5.20m
Net profit
This companyUSD 11.87kMedianUSD 20.66kAverageUSD 86.62k
Operating costs
This companyUSD 521.68kMedianUSD 1.88mAverageUSD 5.04m
Assets
This companyUSD 262.52kMedianUSD 544.32kAverageUSD 1.76m

National Health Fund (NFZ) contracts

Eskulap Choma has been an NFZ healthcare provider since 2024. In 2026 it is performing 1 contract worth USD 1.64k. All its contracts were worth USD 3.85k in total.

NFZ contract value by year (USD)

Type of careNFZ branchContractsValue in 2026
Other services provided in pharmaciesmazowieckie1USD 1.64k

Ownership

Owner
Katarzyna Małgorzata Chomaage 47
Michał Chomaage 50
Zbigniew Marian Chomaage 80

Manner of representation

Each partner independently.

Katarzyna Małgorzata Choma, Michał Choma and Zbigniew Marian Choma – all partners share the same surname, so the structure looks family-owned.

Beneficial owners

Person

Bank accounts

Registered as a VAT taxpayer on 1998-12-19.

Debt

No entries in the National Debtors Register (KRZ).

Real estate

TypeAmount
Buildings and premises
PLN 158K

Public aid

6 public aid cases recorded, with a total value of $14,212.

PurposeGross amount
De minimis aid (in accordance with Commission Regulation 2023/2831)
$1,167
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$819
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$1,282

Regulatory authorisations

AuthorityTypeStatus
BDO register entry Active

Competitors

Name
DR ZdrowieS.A.
MagmaxS.A.
Adpharmasp. z o.o.
Novopharm - Millersp. j.
MaglowS.A.
Farmacja Im. O. Klimuszkisp. z o.o.
Nukloversp. z o.o.
Massmedsp. z o.o.
DR Farm K. Wenda Zakłady Przemysłowo-Handlowe w Warszawie z Siedzibą w WarszawieS.A.
Femaherbsp. z o.o.

Change history

DateEvent
2017-09-11Name change
2001-10-31Entered in the register

FAQ

Last updated: 2026-04-02